Cargando…
Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy
BACKGROUND: Because of increasing safety concerns related to erythropoiesisstimulating agents (ESAs), the Centers for Medicare & Medicaid Services issued a Medicare reimbursement policy change regarding these medications in cancer patients. However, the policy established an absolute hemoglobin...
Autores principales: | Li, Minghui, Schulz, Richard, Chisholm-Burns, Marie, Wang, Junling, Lu, Z. Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390950/ https://www.ncbi.nlm.nih.gov/pubmed/33119441 http://dx.doi.org/10.18553/jmcp.2020.26.11.1477 |
Ejemplares similares
-
Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy
por: Li, Minghui, et al.
Publicado: (2021) -
Racial and ethnic disparities in Medicare Part D medication therapy management services utilization
por: Dong, Xiaobei, et al.
Publicado: (2023) -
Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities
por: Formagini, Taynara, et al.
Publicado: (2021) -
Exploring racial and ethnic disparities in medication adherence among Medicare comprehensive medication review recipients
por: Dong, Xiaobei, et al.
Publicado: (2021) -
Racial and ethnic disparities due to Medicare Part D Star Ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia
por: Chisholm-Burns, Marie A, et al.
Publicado: (2022)